Covenantlabs Announces 'Covenant Child' Global OBT Pre-Registration Is Currently in Progress
December 11, 2023 01:20 ET | Covenant Labs CO.,LTD.
SEOUL, KOREA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Smart city integration platform company CityLabs' affiliated company, CovenantLabs, said pre-registration for OBT is currently in progress before...
Citylabs' Affiliated Company, Covenantlabs, 'Covenant Child' Global OBT Pre-Order Will Be Start
December 04, 2023 01:19 ET | Covenant Labs CO.,LTD.
SEOUL, KOREA, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Smart city integration platform company CityLabs' (139050.KQ) affiliated company, CovenantLabs, will begin pre-registration of 'Covenant Child' OBT,...
Research Nester Logo.jpg
Surge Arrester Market revenue to hit USD 3 Billion by 2035, says Research Nester
November 06, 2023 05:30 ET | Research Nester
New York, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The global surge arrester market size is expected to expand at ~4% CAGR from 2023 to 2035. The market is anticipated to garner a revenue of USD 3 billion...
Research Nester Logo.jpg
Dry Type Transformer Market revenue to surpass USD 16 Billion by 2035, says Research Nester
October 17, 2023 07:30 ET | Research Nester
New York, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The global dry type transformer market size is projected to expand at ~9% CAGR between 2023 and 2035. The market is expected to garner a revenue of USD 16...
Picture1.png
Autolus Therapeutics announces Pivotal Phase 2 FELIX study of obe-cel in adult r/r B-ALL selected for an oral presentation at ASCO
April 27, 2023 07:01 ET | Autolus Therapeutics plc
LONDON, April 27, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces...
Picture1.png
Autolus Therapeutics to Host Virtual Capital Markets Day
April 25, 2023 07:00 ET | Autolus Therapeutics plc
LONDON, April 25, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, will host a...
TOMORROW X TOGETHER Selected as KUNDAL's First Brand Ambassador
February 07, 2023 03:00 ET | The Skinfactory Co.,LTD.
SEOUL, KOREA, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Global K-POP artist TOMORROW X TOGETHER has been officially appointed as the first global ambassador of the premium personal care brand "KUNDAL". As a...
[CORRECTION] The Skin Factory (KUNDAL) Acquires Korean Skincare Brand NACIFIC, a Fast-growing K-beauty with the Brand Model 'Stray Kids'
January 16, 2023 06:31 ET | The Skinfactory Co.,LTD.
SEOUL, KOREA, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The Skin Factory, known for its personal care brand 'KUNDAL', plans to further accelerate its overseas sales growth by acquiring Abill Korea, the...
The Skin Factory (KUNDAL) Acquires Korean Skincare Brand NACIFIC, a Fast-growing K-beauty with the Brand Model 'Stray Kids'
January 11, 2023 22:25 ET | The Skinfactory Co.,LTD.
SEOUL, KOREA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The Skin Factory, known for its personal care brand 'KUNDAL', plans to further accelerate its overseas sales growth by acquiring Abill Korea, the...
BES_Mark.jpg
SOUTH JERSEY INDUSTRIES ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of SJI and Encourages Investors to Contact the Firm
February 24, 2022 13:58 ET | Bragar Eagel & Squire
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...